Community Perspectives Associated With the African PsA-TT (MenAfriVac) Vaccine Trials
Open Access
- 9 November 2015
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 61 (suppl_5) , S416-S421
Abstract
Background. The Meningitis Vaccine Project (MVP) was established to address epidemic meningitis as a public health problem in sub-Saharan Africa and, to that end, worked to develop a group A meningococcal conjugate vaccine, PsA-TT. Methods. Experiences in 4 clinical trial sites are described. Culturally sensitive collaborative strategies were adopted to manage acceptable communication methods, peculiarities with the consent process, participant medical issues, community care, and death. Results. The clinical trials were completed successfully through community acceptance and active community collaboration. The trials also strengthened the capacities in the participating communities, and actively worked to resolve community problems. Conclusions. The understanding and integration of sociocultural realities of communities were major assets in the conduct and acceptance of these trials. MVP succeeded in these sites and provided a sound example for future clinical studies in Africa. Clinical Trials Registration. ISRTCN78147026 (PsA-TT 002); ISRCTN87739946 (PsA-TT 003); ISRCTN82484612 (PsA-TT 004); PACTR ATMR2010030001913177 (PsA-TT 006); and PACTR201110000328305 (PsA-TT 007).Keywords
This publication has 13 references indexed in Scilit:
- Safety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and LessonsClinical Infectious Diseases, 2015
- Antibody Persistence 1–5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12–23 Months of AgeClinical Infectious Diseases, 2015
- Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2–29 YearsClinical Infectious Diseases, 2015
- A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy MaliansClinical Infectious Diseases, 2015
- Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate VaccineClinical Infectious Diseases, 2015
- Communication Challenges During the Development and Introduction of a New Meningococcal Vaccine in AfricaClinical Infectious Diseases, 2015
- Negative Rumor: Contagion of a Psychiatric DepartmentThe Primary Care Companion For CNS Disorders, 2014
- Procedures of recruiting, obtaining informed consent, and compensating research participants in Qatar: findings from a qualitative investigationBMC Medical Ethics, 2014
- Impact, Challenges, and Future Projections of Vaccine Trials in AfricaThe American Journal of Tropical Medicine and Hygiene, 2013
- Profile of the Navrongo Health and Demographic Surveillance SystemInternational Journal of Epidemiology, 2012